Literature DB >> 17194729

Prevention of acute mountain sickness by acetazolamide: as yet an unfinished story.

Erik R Swenson, Luc J Teppema.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17194729     DOI： 10.1152/japplphysiol.01407.2006

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN： 0161-7567


× No keyword cloud information.
  10 in total

1.  Acute high-altitude illness: a clinically orientated review.

Authors:  Tom Smedley; Michael Pw Grocott
Journal:  Br J Pain       Date:  2013-05

2.  Acetazolamide during acute hypoxia improves tissue oxygenation in the human brain.

Authors:  Kang Wang; Zachary M Smith; Richard B Buxton; Erik R Swenson; David J Dubowitz
Journal:  J Appl Physiol (1985)       Date:  2015-10-15

3.  Bioavailability, tissue distribution, and excretion characteristics of the novel carbonic anhydrase inhibitor tolsultazolamide in rats.

Authors:  Jin-da Wang; Yong-ping Shi; Jing Yin; Zhi-yuan Pan; Wen-yu Cui; Yan-fang Zhang; Hai Wang
Journal:  Acta Pharmacol Sin       Date:  2013-12-16       Impact factor: 6.150

4.  Effects of low-dose acetazolamide on exercise performance in simulated altitude.

Authors:  Ernst Elisabeth; Gatterer Hannes; Burtscher Johannes; Faulhaber Martin; Pocecco Elena; Burtscher Martin
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2017-04-15

Review 5.  Interventions for preventing high altitude illness: Part 1. Commonly-used classes of drugs.

Authors:  Víctor H Nieto Estrada; Daniel Molano Franco; Roger David Medina; Alejandro G Gonzalez Garay; Arturo J Martí-Carvajal; Ingrid Arevalo-Rodriguez
Journal:  Cochrane Database Syst Rev       Date:  2017-06-27

6.  Discovery of New 1,1'-Biphenyl-4-sulfonamides as Selective Subnanomolar Human Carbonic Anhydrase II Inhibitors.

Authors:  Giuseppe La Regina; Michela Puxeddu; Marianna Nalli; Daniela Vullo; Paola Gratteri; Claudiu Trandafir Supuran; Alessio Nocentini; Romano Silvestri
Journal:  ACS Med Chem Lett       Date:  2019-11-11       Impact factor: 4.345

7.  The noncarbonic anhydrase inhibiting acetazolamide analog N-methylacetazolamide reduces the hypercapnic, but not hypoxic, ventilatory response.

Authors:  Luc J Teppema; Erik R Swenson
Journal:  Physiol Rep       Date:  2015-08

8.  Benzolamide improves oxygenation and reduces acute mountain sickness during a high-altitude trek and has fewer side effects than acetazolamide at sea level.

Authors:  David J Collier; Chris B Wolff; Anne-Marie Hedges; John Nathan; Rod J Flower; James S Milledge; Erik R Swenson
Journal:  Pharmacol Res Perspect       Date:  2016-05-19

Review 9.  High-altitude illnesses: Old stories and new insights into the pathophysiology, treatment and prevention.

Authors:  Martin Burtscher; Urs Hefti; Jacqueline Pichler Hefti
Journal:  Sports Med Health Sci       Date:  2021-04-16

10.  Acute Mountain Sickness Symptom Severity at the South Pole: The Influence of Self-Selected Prophylaxis with Acetazolamide.

Authors:  Michael F Harrison; Paul J Anderson; Jacob B Johnson; Maile Richert; Andrew D Miller; Bruce D Johnson
Journal:  PLoS One       Date:  2016-02-05       Impact factor: 3.240
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.